Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miralax vs. Golytely for Colonoscopy Bowel Preparation
NCT01170754Phase 4Completed
- Sponsor
- Temple University
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 3350 in colorectal cancer (CRC), sponsored by Temple University. Started Apr 2010; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01170754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170754.